Loading…
Loading…
The moves that matter — curated from across forex, stocks and crypto, and readable in full right here.
Updated 18 Aug, 01:00 am
RBC Capital upgraded CAE Inc. to Outperform, citing robust Q1 fiscal 2027 results. The company reported strong financial performance, with revenues of $847.64 million and earnings per share (EPS) of $0.19 , both exceeding analyst estimates. CAE demonstrated significant improvemen
IES Holdings (NASDAQ: IESC) is set to perform a 2-for-1 stock split on August 24, 2026, aiming to enhance share affordability for investors . The company is strategically expanding its market position through the acquisition of DBM Global, Inc. for $650 million , involving a sign
Analysts show strong confidence in Snowflake (NYSE: SNOW) , with multiple firms raising price targets and selecting it as a top pick. Snowflake's stock has demonstrated robust recent performance, significantly outpacing the S&P 500 over the past month. The company anticipates sub
Analyst firm Jefferies issued a "Buy" rating for Elastic, coinciding with a significant stock price surge. Strong market demand for Elastic's Elasticsearch platform and AI-powered tools is driving revenue growth. Institutional investors are increasing their stakes in Elastic, ahe
Cohen & Steers (NYSE: CNS) Stock Analysis: Price Target Raised Amid Index Adjustments and Dividend Declaration Cohen & Steers (NYSE: CNS), a global investment manager, is adjusting its key real estate indexes. An analyst from Evercore ISI raised the Cohen & Steers sto
Citius Pharmaceuticals (NASDAQ: CTXR) Reports Fiscal Q3 Results as LYMPHIR Demand Builds Citius Pharmaceuticals (NASDAQ: CTXR) reported a loss per share that was slightly smaller than the analyst consensus estimate. Quarterly revenue fell short of market expectations, although in
Pinnacle Financial Partners renewed its multi-year partnership with 23XI Racing, enhancing its brand visibility and community engagement. Wells Fargo (NYSE: WFC) analyst Terry McEvoy initiated coverage on the regional bank, signaling positive market sentiment. The analyst set a p
Aviva (OTC: AIVAF) reported robust financial results, surpassing analyst expectations for both earnings and revenue, signaling strong operational performance. The company demonstrated significant growth with a 24% increase in operating profit and a 42% rise in gross written premi
Mixed Q3 Financials: HIVE Digital Technologies (NASDAQ: HIVE) surpassed analyst expectations for earnings per share (EPS) but reported revenue that fell short of estimates, indicating a mixed financial performance for the quarter. Strategic Expansion & Profitability Challenges: T
Strategic Focus: Duos Technologies Group (NASDAQ: DUOT) has sharpened its focus on Edge Data Center solutions by divesting its rail technology subsidiary. Upcoming Earnings: The company is poised to release its quarterly earnings report on August 17, 2026, with analysts projectin
Morgan Stanley Initiates Coverage on Ryanair Holdings plc (NASDAQ: RYAAY) with Overweight Rating Morgan Stanley initiated coverage on Ryanair Holdings plc with an Overweight rating and a price target of $62.90 , suggesting a 6.95% upside from its current stock price. Ryanair demo
HSBC's "Buy" rating and new $60.00 price target for YPF (NYSE: YPF) signal a potential 19.88% upside, reflecting confidence in the energy stock . The Argentine energy company reported robust Q2 2026 financial results , with earnings per share of $3.07 and revenues of $6.57 billio
Analyst firm Barrington raised its price target for ICF International (NASDAQ: ICFI) to $110.00 , indicating a potential upside of 24.45% from the stock's price of $88.39 at the time of the announcement. ICF International projects a return to growth in 2026, with anticipated 3% r
HSBC has upgraded its rating on YPF (NYSE: YPF) to Buy, reflecting increased confidence in the Argentine energy company. YPF reported robust Q2 2026 financial results, with earnings per share of $3.07 and revenues climbing 41.7% year-over-year to $6.57 billion . Future growth is
Vivos Therapeutics surpassed analyst expectations for Q2 2026 earnings per share (EPS) , reporting -$0.31 against an estimated -$0.42 . Despite the EPS beat, Vivos Therapeutics ' revenue for the quarter reached $5.15 million , falling short of the analyst consensus of $5.63 milli
Market Surges: Wetour Robotics Leads Biotech and Technology Stock Gains Wetour Robotics Limited (NASDAQ: WETO) led the market’s gainers with a 127.70% increase. Biotechnology stocks also advanced, with Capricor Therapeutics, Inc. (NASDAQ: CAPR) rising sharply following a po
Several prominent companies, including SoundThinking, Inc. (NASDAQ: SSTI) , TSS, Inc. (NASDAQ: TSSI) , and ADI Global Distribution Inc. (NYSE: ADIG) , experienced significant stock declines amid high trading volumes. Reasons for these drops varied, from negative revenue outlooks
An analyst from Roth Capital set a price target for Genasys , indicating a potential 108% increase from its trading price, highlighting a strong investment outlook. Despite a revenue decrease to $7.3 million in Q3 2026, Genasys attributes this to temporary supply-chain constraint
Headlines provided by Investing.com